Mediwound Stock Analysis

Mediwound Stock Analysis Notes

About 20.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 2.91. Mediwound had not issued any dividends in recent years. The entity had 1:7 split on the 20th of December 2022. MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel. Mediwound operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 77 people. To find out more about Mediwound contact the company at 972 7 797 14100 or learn more at https://www.mediwound.com.

Mediwound Investment Alerts

Mediwound Upcoming and Recent Events

Mediwound Largest EPS Surprises

View All Earnings Estimates

Mediwound Environmental, Social, and Governance (ESG) Scores

Mediwound Thematic Classifications

Mediwound Stock Institutional Investors

Note, although Mediwound's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Mediwound Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 210.4 M.

Mediwound Profitablity

The company has Profit Margin (PM) of (0.99) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.89) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.89.

Management Efficiency

Mediwound has return on total asset (ROA) of (0.1577) % which means that it has lost $0.1577 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7566) %, meaning that it created substantial loss on money invested by shareholders. Mediwound's management efficiency ratios could be used to measure how well Mediwound manages its routine affairs as well as how well it operates its assets and liabilities. As of February 7, 2025, Return On Tangible Assets is expected to decline to -0.12. In addition to that, Return On Capital Employed is expected to decline to -0.33. At present, Mediwound's Non Currrent Assets Other are projected to decrease significantly based on the last few years of reporting. The current year's Asset Turnover is expected to grow to 0.30, whereas Other Assets are forecasted to decline to about 311.2 K.

Technical Drivers

As of the 7th of February, Mediwound secures the Downside Deviation of 2.88, mean deviation of 2.37, and Risk Adjusted Performance of 0.0495. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mediwound, as well as the relationship between them. Please verify Mediwound treynor ratio, and the relationship between the standard deviation and downside variance to decide if Mediwound is priced some-what accurately, providing market reflects its recent price of 19.5 per share. Given that Mediwound has jensen alpha of 0.1286, we recommend you to check Mediwound's last-minute market performance to make sure the company can sustain itself at a future point.

Mediwound Price Movement Analysis

Mediwound Outstanding Bonds

Mediwound Predictive Daily Indicators

Mediwound Corporate Filings

Mediwound Forecast Models

Mediwound's time-series forecasting models are one of many Mediwound's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Mediwound's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Mediwound prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Mediwound shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Mediwound. By using and applying Mediwound Stock analysis, traders can create a robust methodology for identifying Mediwound entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Mediwound analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Mediwound analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Mediwound stock analysis indicators help investors evaluate how Mediwound stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Mediwound shares will generate the highest return on investment. By understating and applying Mediwound stock analysis, traders can identify Mediwound position entry and exit signals to maximize returns.

When running Mediwound's price analysis, check to measure Mediwound's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mediwound is operating at the current time. Most of Mediwound's value examination focuses on studying past and present price action to predict the probability of Mediwound's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mediwound's price. Additionally, you may evaluate how the addition of Mediwound to your portfolios can decrease your overall portfolio volatility.